 |
|
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2022;28(3):553-564. Published online 2022 May 11 DOI: https://doi.org/10.3350/cmh.2022.0082
|
|
Citations to this article as recorded by
 Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac
Li-Na Zhang, Jing-Tong Tan, Ho-Yu Ng, Yun-Shi Liao, Rui-Qi Zhang, Kwok-Hung Chan, Ivan Fan-Ngai Hung, Tommy Tsan-Yuk Lam, Ka-Shing Cheung
Vaccines.2024; 12(4): 365. CrossRef Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Ka Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, Lok Ka Lam, Lung Yi Mak, Yuen Chi Ho, Jing Tong Tan, Esther W. Chan, Wai Kay Seto, Man Fung Yuen, Wai K. Leung
Hepatology.2024; 80(4): 916. CrossRef Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
Ka Shing Cheung, Vincent K C Yan, Xuxiao Ye, Ivan F N Hung, Esther W Chan, Wai K Leung
Journal of Gastroenterology and Hepatology.2024; 39(9): 1837. CrossRef Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan F N Hung, Wai Kay Seto, Man Fung Yuen, Ka Shing Cheung
Journal of Gastroenterology and Hepatology.2024; 39(11): 2386. CrossRef Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao
BMC Gastroenterology.2024;[Epub] CrossRef Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 176. CrossRef Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms.2023; 11(2): 452. CrossRef COVID-19 and MAFLD/NAFLD: An updated review
Ali Nowroozi, Sara Momtazmanesh, Nima Rezaei
Frontiers in Medicine.2023;[Epub] CrossRef Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients
Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuen
Vaccines.2023; 11(3): 497. CrossRef Research Progress of Novel Coronavirus Vac-cine in Patients with Chronic Liver Disease
露 王
Advances in Clinical Medicine.2023; 13(04): 6745. CrossRef SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Hendrik Luxenburger, Robert Thimme
Gut.2023; 72(9): 1783. CrossRef COVID-19 and Fatty Liver Disorders
Maria Guarino, Valentina Cossiga, Francesco Cutolo, Maria Attanasio, Raffaele Lieto, Filomena Morisco
Journal of Clinical Medicine.2023; 12(13): 4316. CrossRef Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort
Ka Shing Cheung, Vincent K. C. Yan, Lok Ka Lam, Xuxiao Ye, Ivan F. N. Hung, Esther W. Chan, Wai K. Leung
Vaccines.2023; 11(8): 1341. CrossRef Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants
Chomchanat Tubjaroen, Sittichoke Prachuapthunyachart, Nattakoon Potjalongsilp, Pimpayao Sodsai, Nattiya Hirankarn, Peera Jaru-Ampornpan, Voranush Chongsrisawat
Vaccines.2022; 10(11): 1867. CrossRef
|